✦ LIBER ✦

Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease

✍ Scribed by Maria Siano; Fabiola De Gregorio; Bartolo Boggia; Angela Sepe; Pasqualina Ferri; Paolo Buonpensiero; Antonio Di Pasqua; Valeria Raia

Book ID: 119229592
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 157 KB
Volume: 42
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2009.07.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic acid in cystic fibrosis-

Ursodeoxycholic acid in cystic fibrosis-associated liver disease

✍ Chee Y. Ooi; Scott Nightingale; Peter R. Durie; Steven D. Freedman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Effects of ursodeoxycholic acid therapy

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

✍ Carla Colombo; Kenneth D.R. Setchell; Mauro Podda; Andrea Crosignani; Aldo Roda; 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 685 KB

Ursodeoxycholic acid for liver disease a

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial

✍ C Colombo; P M Battezzati; M Podda; N Bettinardi; A Giunta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

AND THE ITALIAN GROUP FOR THE STUDY OF URSODEOXYCHOLIC ACID IN CYSTIC FIBROSIS\* ment. Thus, we concluded that UDCA administration im-Liver disease is increasingly recognized as a major proves clinical and biochemical parameters in CF pacause of morbidity in cystic fibrosis (CF). Preliminary tients

Ursodeoxycholic acid for liver disease a

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial

✍ C Colombo; PM Battezzati; M Podda; N Bettinardi; A Giunta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Genetic Risk Factor for Liver Disease fo

Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis

✍ Leslie H. Lang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Endogenous ursodeoxycholic acid and chol

Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis

✍ Jeffery L. Smith; Peter J. Lewindon; Anita C. Hoskins; Tamara N. Pereira; Kennet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

Focal biliary cirrhosis causes significant morbidity and mortality in cystic fibrosis (CF). Although the mechanisms of pathogenesis remain unclear, bile acids have been proposed as potential mediators of liver injury. This study examined bile acid composition in CF and assessed altered bile acid pro